PubMed · 2019 · 11 citations · 18 references
Life SciencesCancer BiologyMolecular BiologyCarcinogenesisDrug DiscoveryMolecular OncologyDna Damage SignalingDna LigaseTumor Suppressor GenesE3 Ubiquitin Ligase Substrate RecognitionHigh-throughput Screening AssaysOncology-related Protein-protein Interaction TargetsOsteosarcoma TreatmentProtein-protein Interaction Inhibitor DiscoverySubstrate Recognition In Ubiquitin Pathways
tumor growth. Collectively, our results suggest that TSC01682 is a potent compound capable of disrupting the CUL4B-DDB1 interaction, and it may be developed as a chemotherapeutic drug for osteosarcoma treatment.
18
Hideo Nishitani, Yasushi Shiomi, Hiroka Iida et al. · Journal of Biological Chemistry · 2008 · 241 citations · Full text